Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.48 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MPI | P34949 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9629001 | 0.81 | TRPM4 (0.48) | TRPM4NQO2ALDH1A1HSD17B10HIF1A | |
| SCHEMBL11323520 | 0.79 | HPRT1 (0.50) | TRPM4ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL1133961 | 0.77 | TRPM4 (0.45) | TRPM4NQO2ALDH1A1HSD17B10HIF1A | |
| SCHEMBL14913815 | 0.77 | TRPM4 (0.45) | TRPM4NQO2ALDH1A1HSD17B10HIF1A | |
| SCHEMBL13542119 | 0.77 | TRPM4 (0.45) | TRPM4NQO2ALDH1A1HSD17B10HIF1A | |
| SCHEMBL3083764 | 0.77 | TRPM4 (0.45) | TRPM4NQO2ALDH1A1HSD17B10HIF1A | |
| SCHEMBL7882102 | 0.77 | TRPM4 (0.45) | TRPM4NQO2ALDH1A1HSD17B10HIF1A | |
| SCHEMBL1133568 | 0.77 | PLAU (0.47) | TRPM4NQO2ALDH1A1HSD17B10HIF1A | |
| SCHEMBL20977726 | 0.77 | TRPM4 (0.45) | TRPM4NQO2ALDH1A1HSD17B10HIF1A | |
| SCHEMBL28347820 | 0.77 | TRPM4 (0.45) | TRPM4NQO2ALDH1A1HSD17B10HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250186323-A1 | COMPOSITION FOR SKIN WHITENING COMPRISING CARVEDILOL | GMEX (GLOBAL MEDICAL XYNAPSE) (KR) | 2025-06-12 | — | — | US | claimed |
| US-20230150924-A1 | NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND | CELLGENTEK CO., LTD. (KR) | 2023-05-18 | — | — | US | claimed |
| EP-4019495-A1 | NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND | Cellgentek Co., Ltd (KR) | 2022-06-29 | — | — | EP | claimed |
| US-10987296-B2 | Composition for improving skin wrinkle containing exopolysaccharide produced by Ceriporia lacerata as active ingredient | FUGENBIO CO., LTD. (KR) | 2021-04-27 | — | — | US | claimed |
| WO-2021034087-A1 | NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND | 주식회사 셀젠텍 | 2021-02-25 | — | — | WO | claimed |
| US-10479787-B2 | Process for preparation of tetrabenazine and deutetrabenazine | LUPIN LIMITED (IN) | 2019-11-19 | — | — | US | claimed |
| US-20190135803-A1 | NOVEL PROCESS FOR PREPARATION OF TETRABENAZINE AND DEUTETRABENAZINE | LUPIN LIMITED (IN) | 2019-05-09 | — | — | US | claimed |
| US-20190008748-A1 | COMPOSITION FOR IMPROVING SKIN CONDITION CONTAINING EXOPOLYSACCHARIDE PRODUCED BY CERIPORIA LACERATA AS ACTIVE INGREDIENT | FUGENBIO CO., LTD. (KR) | 2019-01-10 | — | — | US | claimed |
| WO-2017182916-A1 | NOVEL PROCESS FOR PREPARATION OF TETRABENAZINE AND DEUTETRABENAZINE | LUPIN LIMITED (IN) | 2017-10-26 | — | — | WO | claimed |
| CN-105399669-A | Dihydroxy isoquinoline and preparation method and application thereof from centipedes | UNIV CHINA PHARMA | 2016-03-16 | — | — | CN | claimed |
| CN-105294561-A | Type of isoquinoline as well as preparation method and application thereof | UNIV CHINA PHARMA | 2016-02-03 | — | — | CN | claimed |
| EP-1962843-B1 | USE OF PARP-1 INHIBITORS | PHARMA MAR SA (ES) | 2011-02-23 | — | — | EP | claimed |
| EP-1237871-A2 | NOVEL SUBSTITUTED PHENANTHRIDINONES AND METHODS OF USE THEREOF | Inotek Corporation (US) | 2002-09-11 | — | — | EP | claimed |
| WO-2001042219-A2 | NOVEL SUBSTITUTED PHENANTHRIDINONES AND METHODS OF USE THEREOF | INOTEK CORPORATION (US) | 2001-06-14 | — | — | WO | claimed |
| WO-1999008680-A1 | METHOD OF USING SELECTIVE PARP INHIBITORS TO PREVENT OR TREAT NEUROTOXICITY | THE JOHNS HOPKINS UNIVERSITY (US) | 1999-02-25 | — | — | WO | claimed |
| WO-1998027975-A1 | POLY(ADP-RIBOSE) POLYMERASE INHIBITORS TO TREAT DISEASES ASSOCIATED WITH CELLULAR SENESCENCE | GERON CORPORATION (US) | 1998-07-02 | — | — | WO | claimed |
| EP-0238060-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS | Banyu Pharmaceutical Co., Ltd. (JP) | 1992-01-08 | — | — | EP | claimed |
| JP-1259033-A | — | — | None | — | — | JP | disclosed |
| US-4116953-A | 2-PHENYL-3,1-BENZOXAZIN-4-ONES, PIGMENTS | BASF AKTIENGESELLSCHAFT (DE) | 1978-09-26 | — | — | US | disclosed |
| US-4016151-A | Phenyl-substituted phthalazone azo dyes with a coupling component of the phenol, napthol, acetoacetarylide, pyrazolone, quinolone, pyridine, pyrimidone or isoquinolone series | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190135803-A1 | NOVEL PROCESS FOR PREPARATION OF TETRABENAZINE AND DEUTETRABENAZINE | KAT5, KAT2A, KAT2B | TRPM4 1204/4885NQO2 1650/4885ALDH1A1 627/4885 |
| US-20250186323-A1 | COMPOSITION FOR SKIN WHITENING COMPRISING CARVEDILOL | TYR, CREBBP, MITF | TRPM4 585/4885NQO2 2800/4885ALDH1A1 1715/4885 |
| US-20230150924-A1 | NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND | KNTC1, MED1, LEF1 | TRPM4 1845/4885NQO2 3817/4885ALDH1A1 1404/4885 |
| US-10479787-B2 | Process for preparation of tetrabenazine and deutetrabenazine | KAT5, KAT2A, KAT2B | TRPM4 1495/4885NQO2 1553/4885ALDH1A1 659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.